VentraSciencesTrending

An adamantane-modified analog of the ACTH(4-10)-derived peptide Semax, supplied for structure-activity research. For laboratory research use only.
Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.
Technical specifications
Adamax is a synthetic analog of Semax, the ACTH(4-10)-derived heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, carrying an N-terminal acetyl group and a C-terminal adamantane carboxamide. No peer-reviewed studies of Adamax itself have been published; the references below cover its parent sequence and the adamantane modification.
Research applications: Supplied for structure-activity studies of ACTH(4-10)-derived peptides and analytical characterization of adamantane-modified peptide analogs.
Peer-reviewed research
References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.
By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
Exclusive updates and restock alerts, straight to your inbox.